• First Patients Undergo Surgery In Northwest Biotherapeutics' Phase II Brain Cancer Trial
  Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB), a biotechnology company focused on cancer immunotherapy, today announced that the first two patients in its pivotal Phase II clinical trial have undergone surgery for newly diagnosed Glioblast
  in Public bookmarks with biotherapeutics biotherapy cancer dcvax-brain dcvax-prostate glioblastoma immunotherapy multiforme news northwest patients pivotal therapy treatment trial by 2 users
• TagTooga : health / adult medicine
  The DCVax(R)-Brain Phase II clinical trial is based on two Phase I studies carried out at UCLA under the direction of Linda Liau, M.D., Ph.D., Director of the Malignant Brain Tumor Program at the UCLA School of Medicine. Each of the trials included both n
  in Public bookmarks with biology cancertreatment clinicaltrials dcvax-brain dcvax-prostate dendridiccells neurosurguryblog northwestbiotherapeutics phases technology testing

dcvax-prostate from all users